Annual report [Section 13 and 15(d), not S-K Item 405]

Shareholders' Equity and Capital Stock - Additional Disclosure (Details)

v3.25.4
Shareholders' Equity and Capital Stock - Additional Disclosure (Details)
 1 Months Ended 12 Months Ended
Jul. 29, 2024
USD ($)
$ / shares
shares
Feb. 28, 2023
shares
Feb. 21, 2023
USD ($)
$ / shares
shares
Feb. 28, 2021
$ / shares
shares
Dec. 31, 2025
USD ($)
$ / shares
shares
Dec. 31, 2024
USD ($)
$ / shares
shares
Dec. 31, 2025
$ / shares
May 29, 2020
USD ($)
Shareholders Equity and Capital Stock                
Common shares, unlimited         Unlimited Unlimited    
Common share par value | $ / shares         $ 0 $ 0    
Common share issued         378,169,709 364,101,038    
Common share outstanding         378,169,709 364,101,038    
Basic | $ / shares         $ (0.2) $ (0.17)    
Diluted | $ / shares         $ (0.2) $ (0.17)    
Net proceeds from common stock issuance | $         $ 15,983,000 $ 97,568,000    
Shares issued upon public offering 57,150,000   34,000,000          
Warrants to purchase     17,000,000          
Public offering price per share | $ / shares $ 1.05   $ 1.18          
Exercise price | $ / shares     $ 1.5          
Class of warrant or right, expiry term     3 years          
Period of option to purchase additional shares by underwriter 30 days   30 days          
Additional common shares purchase 8,572,500   5,100,000          
Additional warrants purchase     2,550,000          
Warrants issued to purchase common shares 65,722,500              
Purchase warrants     19,550,000   19,136,750      
Gross proceeds with warrants | $ $ 69,000,000   $ 46,100,000          
Fees and expenses | $ 3,800,000   3,000,000          
Net proceeds from offerings | $ 65,200,000   $ 43,100,000          
Number of warrants, Exercised         (767,500) (16,376,500)    
Options exercised | $         $ 1,200,000 $ 1,300,000    
Exercise of stock options         2,568,097 2,351,563    
Grants of options, term         3 years      
Service term option         5 years      
Intrinsic value of date of grant | $ / shares         $ 0      
Grant date fair value of options granted | $ / shares         $ 1 $ 1.01    
Intrinsic value of options exercised | $         $ 2,000,000 $ 1,700,000    
Number of common shares to be issued         1      
Employee Service Share-based Compensation Period for Recognition         2 years 6 months      
Closing stock price per share | (per share)         $ 1.39   $ 1.88  
Money stock options outstanding         4,437,440      
Money stock options exercisable         2,629,317      
Stock option liabilities | $         $ 1,346 1,758    
Increase in deferred tax assets | $         925,000 822,000    
Fair value of RSUs vested | $         $ 800,000 $ 100,000    
Class A Preferred shares                
Shareholders Equity and Capital Stock                
Preferred shares, unlimited         Unlimited Unlimited    
Preferred shares, par value | $ / shares         $ 0 $ 0    
Preferred shares issued         0 0    
Preferred shares outstanding         0 0    
US                
Shareholders Equity and Capital Stock                
Stock option liabilities | $ $ 2,500,000       $ 1,300,000 $ 1,800,000    
Restricted Stock Units RSU One [Member]                
Shareholders Equity and Capital Stock                
Restricted stock expense | $         500,000 500,000    
Unamortized stock-based compensation expenses | $         $ 1,200,000      
Employee Service Share-based Compensation Period for Recognition         1 year 8 months 12 days      
Warrants One [Member]                
Shareholders Equity and Capital Stock                
Warrants issued to purchase common shares   39,100,000 39,100,000 16,930,530        
Gross proceeds with warrants | $         $ 600,000 11,100,000    
Common shares purchase     19,550,000 8,465,265        
Market price | $ / shares     $ 1.5 $ 1.35        
Warrant term   3 years   3 years        
Equity Option                
Shareholders Equity and Capital Stock                
Unamortized stock-based compensation expenses | $         3,300,000      
Stock-based compensation expense | $         1,100,000 800,000    
Increase in deferred tax assets | $         100,000 100,000    
Common Shares                
Shareholders Equity and Capital Stock                
Net proceeds from common stock issuance | $         $ 15,600,000 $ 27,800,000    
Warrants issued to purchase common shares         10,619,331 16,939,825    
Common stock shares sold | $         $ 16,000,000 $ 28,600,000    
Common stock issued costs | $         400,000 700,000    
Warrants exercised | $         $ 600,000 $ 11,100,000    
Number of warrants exercised         383,750 8,188,250    
Number of warrants, Exercised         767,500 16,376,500    
Options exercised | $         $ 1,200,000 $ 1,300,000    
Exercise of stock options         2,568,097 2,351,563    
Common shares issued         497,493 0    
Number of RSUs shares released         588,290 39,233    
Agents for aggregate sales proceeds | $               $ 100,000,000
First anniversary                
Shareholders Equity and Capital Stock                
Percentage of grant option         33.33%      
Second anniversary                
Shareholders Equity and Capital Stock                
Percentage of grant option         33.33%      
Third anniversary                
Shareholders Equity and Capital Stock                
Percentage of grant option         33.33%